Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Mabvax Therapeutics for $150,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA153561-01 | Phase I | 150,000 | ||||||||
A SBIR Phase II contract was awarded to Mabvax Therapeutics for $1,499,434.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201300060C-4-0-1 | Phase II | 1,499,434 | ||||||||
A SBIR Phase II contract was awarded to Mabvax Therapeutics for $1,845,939.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA153561-02 | Phase II | 1,845,939 | ||||||||
A STTR Phase I contract was awarded to Mabvax Therapeutics for $201,826.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA128363-01A1 | Phase I | 201,826 | ||||||||
A SBIR Phase I contract was awarded to Mabvax Therapeutics for $249,965.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CA130060 | Phase I | 249,965 | ||||||||
A SBIR Phase I contract was awarded to Mabvax Therapeutics for $149,152.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA171392-01 | Phase I | 149,152 | ||||||||
A STTR Phase I contract was awarded to Mabvax Therapeutics for $197,764.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA128362-01A1 | Phase I | 197,764 | ||||||||
A STTR Phase II contract was awarded to Mabvax Therapeutics for $1,104,720.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42CA128362-02 | Phase II | 1,104,720 |